ENTITY
Kalbe Farma

Kalbe Farma (KLBF IJ)

183
Analysis
Health Care • Indonesia
PT Kalbe Farma Tbk produces and develops pharmaceutical products for human and animal healthcare. Through its subsidiaries, the Company also operates in the pharmaceutical, health food, and packaging industries.
more
bullish•Cross Asset Strategy
•27 Jan 2025 16:55•Exchange-sponsored

The Shift Of Supply Chains From China To Southeast Asia

China’s rise as a global manufacturing hub was fueled by WTO accession in 2001, supported by export-friendly policies, low-cost labor, and rapid...

Logo
531 Views
Share
•19 Dec 2024 09:41•Broker

Consumer: FY25 Outlook: Growth Drivers from Supported Purchasing Power and Strategic Pricing

We expect higher minimum wages in FY25 and a positive impact from purchasing power and govt’s meal program to create more jobs.

Logo
299 Views
Share
•02 Dec 2024 11:26

The Stocks to Own in ASEAN – Vol. 49

We highlight 14 stocks in ASEAN that look interesting to us based on our FVMR Methodology. Portfolio changes: Three stocks remain, 11 stocks added.

Share
bullish•Kalbe Farma
•19 Nov 2024 20:26•Broker

Kalbe Farma - Healthy FY25 Growth Outlook Intact Despite ST Rupiah Headwinds

Solid prescription revenue and operating efficiency drove strong 9M24 net and core profit growth of 15.2%/10% yoy. We estimate healthy FY25 net...

Logo
349 Views
Share
•12 Oct 2024 06:41•Broker

Consumer: Sustained Solid Core Profit Growth on Stable Margins, in Line with Our and Consensus

We estimate 3Q24/9M24 sector revenue growth of +2.6%/+4% yoy and 9M24 operating profit of +7% yoy, in line with our and cons. est.

Logo
466 Views
Share
x